Norovirus Vaccine (Virus-Like Particles)
This norovirus vaccine candidate uses virus-like particles (VLPs) produced by recombinant technology to mimic the viral capsid and induce immunity. It is designed to prevent acute gastroenteritis caused by norovirus. As a biotechnologically obtained vaccine, it is classified under tariff item 3002.49.00 as an 'other' vaccine.
Import Duty Rates by Country of Origin
| Origin Country | MFN Tariff | Surtaxes | Total Effective Rate |
|---|---|---|---|
| 🇨🇳China | Free | — | Free |
| 🇲🇽Mexico | Free | — | Free |
| 🇺🇸United States | Free | — | Free |
| 🇩🇪Germany | Free | — | Free |
| 🇯🇵Japan | Free | — | Free |
More Specific Codes
This product may fall under a more specific subheading:
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If the vaccine is combined with an immunostimulant adjuvant
Vaccines with adjuvants may be classified under a different subheading for mixed immunological products.
Not sure which classification is right?
The Tariff Assistant works through the GRI rules on your specific product to reach the right tariff item — and can price the duty on it in the same conversation.
Import Tips & Compliance
• If the vaccine is investigational, obtain a Clinical Trial Application (CTA) approval from Health Canada
• Provide documentation of the recombinant production process
• Ensure the product is shipped with proper cold-chain management and log all temperature data
Related Products under Tariff item 3002.49.00
Anthrax Vaccine Adsorbed (AVA)
Anthrax Vaccine Adsorbed (AVA), known as BioThrax, is a cell-free vaccine prepared from protective antigen of Bacillus anthracis adsorbed to aluminum hydroxide. It is used to induce immunity against anthrax in military personnel and emergency responders. This vaccine falls under tariff item 3002.49.00 as an 'other' vaccine derived from micro-organisms, not specifically named elsewhere in the subheading.
Chlamydia Vaccine (Recombinant)
This recombinant chlamydia vaccine uses the major outer membrane protein (MOMP) produced through biotechnological processes, combined with an adjuvant. It is designed to prevent trachoma and sexually transmitted chlamydial infections. As a vaccine obtained by biotechnological means, it is classified under tariff item 3002.49.00 as an 'other' vaccine.
Cholera Vaccine (Oral Recombinant)
Dukoral is an oral cholera vaccine containing inactivated Vibrio cholerae whole cells and recombinant cholera toxin B subunit. It provides mucosal immunity against cholera and is administered as an oral suspension with a buffer solution. This vaccine is classified under tariff item 3002.49.00 as an 'other' vaccine, as it is not specifically named in other subheadings.
Dengue Vaccine (Tetravalent Live Attenuated)
Dengvaxia is a tetravalent live-attenuated vaccine against dengue fever, created using recombinant DNA technology with a yellow fever 17D backbone. It is indicated for individuals with prior dengue infection to prevent severe disease. As a vaccine obtained by biotechnological processes, it falls under tariff item 3002.49.00 as an 'other' vaccine.
Inactivated Polio Vaccine (IPV)
Inactivated Polio Vaccine (IPV) contains killed poliovirus strains (types 1, 2, and 3) that stimulate protective immunity without causing disease. It is used in routine childhood immunization and booster doses. This vaccine is classified under tariff item 3002.49.00 as an 'other' vaccine for prophylactic use in humans.
Japanese Encephalitis Vaccine (Inactivated)
Ixiaro is an inactivated Japanese encephalitis vaccine produced from Vero cell cultures, used for active immunization of adults and children traveling to endemic areas. It is a purified, inactivated whole-virus vaccine. This product falls under tariff item 3002.49.00 as an 'other' vaccine derived from micro-organisms.